When Amanda Van Annan set out to create skincare that truly outperformed, she didn’t start with packaging or trends – she started with a question: what if active ingredients could reach deeper, where real transformation begins?

Her search took her around the world, meeting laboratories and scientists across continents. At a conference, a chance conversation with Alex Emelyanov changed everything. When Amanda shared her vision for deeper penetration of actives to deliver clinic‑level results at home, Alex told her about his grandmother, Dr. Inga Vladimirovna Emelyanova – a renowned chemist, Ph.D. and “Distinguished Inventor of the Russian Federation,” recognised in 2006 for her contributions to technological progress.

Dr. Emelyanova had spent years developing TD1X, a patented molecule used by doctors in Russia to help pharmaceutical actives penetrate more effectively, supported by multiple medical research papers. Until that moment, no one had considered applying this breakthrough to beauty.

Amanda saw the potential instantly. She partnered with Alex and the laboratory, beginning a three‑year journey of formulating and testing. Together, they combined TD1X with carefully selected, high‑performance actives, running clinical and consumer trials to validate every step. The result: advanced formulations designed not only to penetrate deeper, but to help reset skin at a mitochondrial level – supporting longevity, repair and visible renewal from within.

Today, Aye Life Sciences stands at the intersection of elegant ritual and rigorous science. What began as a chance meeting has become a platform for ongoing innovation, as the team continues to develop new TD1X‑powered solutions – from next‑generation skincare to targeted vitamin delivery – all with a single purpose: to give skin the future it deserves.